A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women
- 1 April 2016
- Vol. 34 (15) , 1786-1791
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The spectrum of perinatal group B streptococcal diseaseVaccine, 2013
- Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infantsVaccine, 2013
- An overview of global GBS epidemiologyVaccine, 2013
- A maternal vaccine against group B Streptococcus: Past, present, and futureVaccine, 2013
- Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccinesVaccine, 2012
- Safety, Immunogenicity and Dose Ranging of a New Vi-CRM197 Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy AdultsPLOS ONE, 2011
- MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza VaccinesScience Translational Medicine, 2011
- Bacterial Meningitis in the United States, 1998–2007New England Journal of Medicine, 2011
- Use of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccine for Type II Group BStreptococcusin Healthy WomenThe Journal of Infectious Diseases, 2000
- Safety and Immunogenicity of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccines for Group B Streptococcal Types Ia and IbThe Journal of Infectious Diseases, 1999